Literature DB >> 10441986

Advances in understanding and treatment of cough.

J G Widdicombe1.   

Abstract

Many different conditions and diseases cause cough. The commonest acute causes are pollution, including cigarette smoke, and upper respiratory tract infection. The commonest chronic causes are postnasal drip, asthma, chronic bronchitis and gastro-oesophageal reflux. Epidemiological studies give widely different patterns of incidence. The different conditions that cause cough have in common the fact that the cough is mediated via the vagus nerves, with sensory receptors in and under the epithelium from the larynx down to the smaller bronchi. These receptors are polymodal, responding to a large variety of stimuli, including mechanical and chemical irritants, inflammatory mediators, intraluminal material and large volume changes of the lungs. With irritation and inflammation, C fibre receptors release neurokinins such as substance P, which in turn stimulate cough receptors. The central nervous pathways for the cough reflex are poorly understood. They can be activated or inhibited voluntarily. Studies on the pharmacology of the central nervous pathways of coughing are opening up new therapeutic possibilities. Other new therapies include drugs acting on the sensory receptors for cough, thereby avoiding adverse central nervous effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441986

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  4 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

Review 2.  Preclinical assessment of novel therapeutics on the cough reflex: cannabinoid agonists as potential antitussives.

Authors:  Maria G Belvisi
Journal:  Lung       Date:  2007-10-02       Impact factor: 2.584

3.  Participation of thromboxane A(2) in the cough response in guinea-pigs: antitussive effect of ozagrel.

Authors:  K Shinagawa; M Kojima; K Ichikawa; M Hiratochi; S Aoyagi; M Akahane
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Illness behaviour and antibiotic prescription in patients with respiratory tract symptoms.

Authors:  Huug J van Duijn; Marijke M Kuyvenhoven; François G Schellevis; Theo Jm Verheij
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.